Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein translation, also called protein synthesis, is a universally conserved process essential for gene expression, wherein ribosomes synthesize proteins by decoding the genetic instructions carried by messenger RNA. The process proceeds through three main steps—initiation, elongation, and termination—utilizing a complex set of macromolecules including ribosomal subunits, initiation/elongation/release factors, and transfer RNAs. Translation is indispensable for cellular structure, growth, function, and adaptation. Dysregulation of translation contributes to diverse diseases such as cancer, neurodegeneration, metabolic disorders, and infection. Though the process can be targeted by certain drugs (antibiotics, antineoplastics), "protein translation" itself is not a single molecular drug target but a process comprising many potential targetable components (such as specific ribosomal proteins or translation factors).
Inhibition of ribosome function, inhibition of tRNA binding, interference with peptide bond formation, induction of premature chain termination
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein translation process.